Altimmune Inc. (ALT)

0.33 -0.01 (-2.941%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 0.34

Price Open 0.35

Volume: 252,803

Avg Volume: 979,428

Market Cap: 12.7M

P/E Ratio -0.39

52 Wk Range 0.2501-3.16



ALT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
33.38M
1.79M
1.41
5.36%

2018-07-13
33.15M
1.44M
1.39
4.36%

2018-06-29
29.62M
1.15M
1.09
3.90%

2018-06-15
20.74M
1.86M
1.46
8.98%




ALT Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-15
Q1 2018
BTO
-0.50 (1)
-0.23
0.27

2018-05-02
Q1 2018
N/A
-0.50 (1)
0.00
0.00

2018-03-29
Q4 2017
BTO
-0.50 (1)
0.00
0.00

2018-03-28
Q4 2017
BTO
-0.50 (1)
-0.12
0.38

News

Altimmune -9.1% on offering of 58M units (2018-08-17 17:26 SeekingAlpha)

Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more …

 


Statistics

Shares Outstanding: 38.49M

Top 15 Institution Percent: 16.90

Price To Sales: 1.05

Price To Book: 0.35

Revenue: 4.59M

Gross Profit: N/A

Cash: 17.12M

Debt: 639887

Return On Assets: -81.72

Return On Equity: -104.50

Profit Margin: N/A

Price History

Beta: 2.60

50-day Moving Avg: 0.44

200-day Moving Avg: 1.19

YTD Change: -83.50

5-day Change: 0.27

1-month Change: -10.47

3-month Change: -34.65

6-month Change: -77.70

1-year Change: -83.82

Revenue Per Share: 0.00

Revenue Per Employee: 153065.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Altimmune Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.altimmune.com

Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of diseases.